fashion -WSS

fashion

author：Wikipedia 2025-09-03 12:10:17 - browse：69

a person wearing blue dress conducts a finger prick test on another person in a home setting — coverage from STAT — Adobe

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.

A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to manage diabetes with the help of finger-stick blood glucose readings don’t result in clinically meaningful improvements over standard care. As a result, they don’t reduce health care spending — they drive it up.

“Most of the solutions in this category do not deliver clinical benefits that justify their cost,” Caroline Pearson, executive director of the institute, told STAT. Despite finding that some populations may benefit, the report concludes that current evidence doesn’t support broader adoption for most products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Reporting on presidential health from Reagan to Trump and Biden

WSS

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Opioid cravings were reduced by anti

‘The Bear’ and hospitality in hospitals

Medicare Advantage enrollment grows 7.1% to 33.4 million people

CDC launches VaccineFinder tool to locate Covid

leisure time

fashion

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

FTX founder Sam Bankman

As demand for Covid shots wanes, Moderna seeks its next success

Discs beat pads, tampons for heavy menstrual flow, new study shows

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Sports medicine is finally prioritizing gender equality

In venture capital firm's success, lessons for turning crisis into profit

Walensky prepares to leave CDC — and Congress — behind

Hospitals are piloting generative AI tools as regulators play catch

hotspot

As AI regulations shape up, health tech startups beg for clarity

Opioid cravings were reduced by anti

‘The Bear’ and hospitality in hospitals

Measles policy set amid Florida outbreak alarms vaccine proponents

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Hospitals are piloting generative AI tools as regulators play catch

focus

explore

leisure time

explore